PFIZER INC Income (Loss) from Continuing Operations, Net of Tax, Including Portion Attributable to Noncontrolling Interest
PFIZER INC (PFE) reported Income (Loss) from Continuing Operations, Net of Tax, Including Portion Attributable to Noncontrolling Interest of -$246.00 million for the 3-month period ending 2026-06-28, per its 10-Q filed 2026-08-04.
Financial Statements › Expense Statement › Operating Expenses
us-gaap:IncomeLossFromContinuingOperationsIncludingPortionAttributableToNoncontrollingInterest · last filed 2026-08-04
- PFIZER INC income (loss) from continuing operations, net of tax, including portion attributable to noncontrolling interest for the quarter ending 2026-06-28 was -$246.00M, a 108.47% decline year-over-year.
- PFIZER INC income (loss) from continuing operations, net of tax, including portion attributable to noncontrolling interest for the quarter ending 2026-03-29 was $2.71B, a 8.88% decline year-over-year.
- PFIZER INC income (loss) from continuing operations, net of tax, including portion attributable to noncontrolling interest for the quarter ending 2025-12-31 was -$1.64B, a 499.03% decline year-over-year.
- PFIZER INC income (loss) from continuing operations, net of tax, including portion attributable to noncontrolling interest for the quarter ending 2025-09-28 was $3.55B, a 20.78% decline year-over-year.
- PFIZER INC income (loss) from continuing operations, net of tax, including portion attributable to noncontrolling interest for fiscal 2025 was $7.79B, a 3.28% decline from fiscal 2024.
- PFIZER INC income (loss) from continuing operations, net of tax, including portion attributable to noncontrolling interest for fiscal 2024 was $8.05B, a 270.67% increase from fiscal 2023.
- PFIZER INC income (loss) from continuing operations, net of tax, including portion attributable to noncontrolling interest for fiscal 2023 was $2.17B, a 93.08% decline from fiscal 2022.
- PFIZER INC income (loss) from continuing operations, net of tax, including portion attributable to noncontrolling interest for fiscal 2022 was $31.40B, a 39.81% increase from fiscal 2021.
| Period end | Income (Loss) from Continuing Operations, Net of Tax, Including Portion Attributable to Noncontrolling Interest 3 month | Income (Loss) from Continuing Operations, Net of Tax, Including Portion Attributable to Noncontrolling Interest 3 month as first filed | Income (Loss) from Continuing Operations, Net of Tax, Including Portion Attributable to Noncontrolling Interest 6 month | Income (Loss) from Continuing Operations, Net of Tax, Including Portion Attributable to Noncontrolling Interest 6 month as first filed | Income (Loss) from Continuing Operations, Net of Tax, Including Portion Attributable to Noncontrolling Interest 9 month | Income (Loss) from Continuing Operations, Net of Tax, Including Portion Attributable to Noncontrolling Interest 9 month as first filed | Income (Loss) from Continuing Operations, Net of Tax, Including Portion Attributable to Noncontrolling Interest 12 month | Income (Loss) from Continuing Operations, Net of Tax, Including Portion Attributable to Noncontrolling Interest 12 month as first filed |
|---|---|---|---|---|---|---|---|---|
| 2026-06-28 | -$246.00M 10-Q · filed 2026-08-04 | $2.46B 10-Q · filed 2026-08-04 | $823.00M derived: sum of 3 quarters · filed 2026-08-04 | $4.37B derived: sum of 4 quarters · filed 2026-08-04 | ||||
| 2026-03-29 | $2.71B 10-Q · filed 2026-05-05 | $1.07B derived: sum of 2 quarters · filed 2026-05-05 | $4.62B derived: sum of 3 quarters · filed 2026-05-05 | $7.52B derived: sum of 4 quarters · filed 2026-08-04 | ||||
| 2025-12-31 | -$1.64B derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-26 | $1.91B derived: sum of 2 quarters · filed 2026-02-26 | $4.81B derived: sum of 3 quarters · filed 2026-08-04 | $7.79B 10-K · filed 2026-02-26 | ||||
| 2025-09-28 | $3.55B 10-Q · filed 2025-11-04 | $6.45B derived: sum of 2 quarters · filed 2026-08-04 | $9.43B 10-Q · filed 2025-11-04 | $9.84B derived: sum of 4 quarters · filed 2026-08-04 | ||||
| 2025-06-29 | $2.90B 10-Q · filed 2026-08-04 | $5.88B 10-Q · filed 2026-08-04 | $6.29B derived: sum of 3 quarters · filed 2026-08-04 | $10.77B derived: sum of 4 quarters · filed 2026-08-04 | ||||
| 2025-03-30 | $2.97B 10-Q · filed 2026-05-05 | $3.38B derived: sum of 2 quarters · filed 2026-05-05 | $7.87B derived: sum of 3 quarters · filed 2026-05-05 | $7.90B derived: sum of 4 quarters · filed 2026-05-05 | ||||
| 2024-12-31 | $411.00M derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-26 | $4.89B derived: sum of 2 quarters · filed 2026-02-26 | $4.92B derived: sum of 3 quarters · filed 2026-02-26 | $8.05B 10-K · filed 2026-02-26 | ||||
| 2024-09-29 | $4.48B 10-Q · filed 2025-11-04 | $4.51B derived: sum of 2 quarters · filed 2025-11-04 | $7.64B 10-Q · filed 2025-11-04 | $4.30B derived: sum of 4 quarters · filed 2026-02-26 | ||||
| 2024-06-30 | $31.00M 10-Q · filed 2025-08-05 | $3.16B 10-Q · filed 2025-08-05 | -$176.00M derived: sum of 3 quarters · filed 2026-02-26 | -$2.56B derived: sum of 4 quarters · filed 2026-02-26 | ||||
| 2024-03-31 | $3.13B 10-Q · filed 2025-05-05 | -$207.00M derived: sum of 2 quarters · filed 2026-02-26 | -$2.60B derived: sum of 3 quarters · filed 2026-02-26 | -$255.00M derived: sum of 4 quarters · filed 2026-02-26 | ||||
| 2023-12-31 | -$3.33B derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-26 | -$5.72B derived: sum of 2 quarters · filed 2026-02-26 | -$3.38B derived: sum of 3 quarters · filed 2026-02-26 | $2.17B 10-K · filed 2026-02-26 | ||||
| 2023-10-01 | -$2.39B 10-Q · filed 2024-11-04 | -$48.00M derived: sum of 2 quarters · filed 2024-11-04 | $5.51B 10-Q · filed 2024-11-04 | $10.51B derived: sum of 4 quarters · filed 2025-02-27 | ||||
| 2023-07-02 | $2.34B 10-Q · filed 2024-08-05 | $7.89B 10-Q · filed 2024-08-05 | $12.90B derived: sum of 3 quarters · filed 2025-02-27 | $21.54B derived: sum of 4 quarters · filed 2025-02-27 | ||||
| 2023-04-02 | $5.55B 10-Q · filed 2024-05-08 | $10.56B derived: sum of 2 quarters · filed 2025-02-27 | $19.20B derived: sum of 3 quarters · filed 2025-02-27 | $29.08B derived: sum of 4 quarters · filed 2025-02-27 | ||||
| 2022-12-31 | $5.00B derived: 10-K 12 month − 10-Q 9 month · filed 2025-02-27 | $13.65B derived: sum of 2 quarters · filed 2025-02-27 | $23.52B derived: sum of 3 quarters · filed 2025-02-27 | $31.40B 10-K · filed 2025-02-27 | ||||
| 2022-10-02 | $8.64B 10-Q · filed 2023-11-08 | $18.52B derived: sum of 2 quarters · filed 2023-11-08 | $26.40B 10-Q · filed 2023-11-08 | $29.98B derived: sum of 4 quarters · filed 2024-02-22 | ||||
| 2022-07-03 | $9.88B 10-Q · filed 2023-08-09 | $17.76B 10-Q · filed 2023-08-09 | $21.33B derived: sum of 3 quarters · filed 2024-02-22 | $29.50B derived: sum of 4 quarters · filed 2024-02-22 | ||||
| 2022-04-03 | $7.88B 10-Q · filed 2023-05-10 | $11.46B derived: sum of 2 quarters · filed 2024-02-22 | $19.63B derived: sum of 3 quarters · filed 2024-02-22 | $25.45B derived: sum of 4 quarters · filed 2024-02-22 | ||||
| 2021-12-31 | $3.58B derived: 10-K 12 month − 10-Q 9 month · filed 2024-02-22 | $11.75B derived: sum of 2 quarters · filed 2024-02-22 | $17.57B derived: sum of 3 quarters · filed 2024-02-22 | $22.46B 10-K · filed 2024-02-22 | ||||
| 2021-10-03 | $8.17B 10-Q · filed 2022-11-09 | $8.17B 10-Q · filed 2021-11-12 | $14.00B derived: sum of 2 quarters · filed 2022-11-09 | $18.88B 10-Q · filed 2022-11-09 | $18.61B 10-Q · filed 2021-11-12 | $19.54B derived: sum of 4 quarters · filed 2023-02-23 | ||
| 2021-07-04 | $5.83B 10-Q · filed 2022-08-10 | $5.57B 10-Q · filed 2021-08-12 | $10.71B 10-Q · filed 2022-08-10 | $10.44B 10-Q · filed 2021-08-12 | $11.37B derived: sum of 3 quarters · filed 2023-02-23 | $12.29B derived: sum of 4 quarters · filed 2023-02-23 | ||
| 2021-04-04 | $4.88B 10-Q · filed 2022-05-11 | $4.88B 10-Q · filed 2021-05-13 | $5.55B derived: sum of 2 quarters · filed 2023-02-23 | $6.46B derived: sum of 3 quarters · filed 2023-02-23 | $9.07B derived: sum of 4 quarters · filed 2023-02-23 | |||
| 2020-12-31 | $662.00M derived: 10-K 12 month − 10-Q 9 month · filed 2023-02-23 | $1.58B derived: sum of 2 quarters · filed 2023-02-23 | $4.18B derived: sum of 3 quarters · filed 2023-02-23 | $6.67B 10-K · filed 2023-02-23 | $7.02B 10-K · filed 2021-02-25 | |||
| 2020-09-27 | $917.00M 10-Q · filed 2021-11-12 | $2.20B 10-Q · filed 2020-11-05 | $3.52B derived: sum of 2 quarters · filed 2021-11-12 | $6.00B 10-Q · filed 2021-11-12 | $9.05B 10-Q · filed 2020-11-05 | $117.00M derived: sum of 4 quarters · filed 2022-02-24 | ||
| 2020-06-28 | $2.60B 10-Q · filed 2021-08-12 | $3.43B 10-Q · filed 2020-08-06 | $5.09B 10-Q · filed 2021-08-12 | $6.84B 10-Q · filed 2020-08-06 | -$800.00M derived: sum of 3 quarters · filed 2022-02-24 | $6.88B derived: sum of 4 quarters · filed 2022-02-24 | ||
| 2020-03-29 | $2.48B 10-Q · filed 2021-05-13 | $3.41B 10-Q · filed 2020-05-07 | -$3.40B derived: sum of 2 quarters · filed 2022-02-24 | $4.28B derived: sum of 3 quarters · filed 2022-02-24 | $9.33B derived: sum of 4 quarters · filed 2022-02-24 | |||
| 2019-12-31 | -$5.89B derived: 10-K 12 month − 10-Q 9 month · filed 2022-02-24 | $1.79B derived: sum of 2 quarters · filed 2022-02-24 | $6.85B derived: sum of 3 quarters · filed 2022-02-24 | $10.74B 10-K · filed 2022-02-24 | $16.30B 10-K · filed 2020-02-27 | |||
| 2019-09-29 | $7.68B 10-Q · filed 2020-11-05 | $12.74B derived: sum of 2 quarters · filed 2020-11-05 | $16.63B 10-Q · filed 2020-11-05 | $8.92B derived: sum of 4 quarters · filed 2021-02-25 | ||||
| 2019-06-30 | $5.06B 10-Q · filed 2020-08-06 | $8.95B 10-Q · filed 2020-08-06 | $1.24B derived: sum of 3 quarters · filed 2021-02-25 | $5.36B derived: sum of 4 quarters · filed 2021-02-25 | ||||
| 2019-03-31 | $3.89B 10-Q · filed 2020-05-07 | -$3.81B derived: sum of 2 quarters · filed 2021-02-25 | $299.00M derived: sum of 3 quarters · filed 2021-02-25 | $4.18B derived: sum of 4 quarters · filed 2021-02-25 | ||||
| 2018-12-31 | -$7.70B derived: 10-K 12 month − 10-Q 9 month · filed 2021-02-25 | -$3.59B derived: sum of 2 quarters · filed 2021-02-25 | $289.00M derived: sum of 3 quarters · filed 2021-02-25 | $3.86B 10-K · filed 2021-02-25 | $11.18B 10-K · filed 2019-02-28 | |||
| 2018-09-30 | $4.11B 10-Q · filed 2019-11-07 | $7.99B derived: sum of 2 quarters · filed 2019-11-07 | $11.56B 10-Q · filed 2019-11-07 | $23.85B derived: sum of 4 quarters · filed 2020-02-27 | ||||
| 2018-07-01 | $3.88B 10-Q · filed 2019-08-08 | $7.45B 10-Q · filed 2019-08-08 | $19.74B derived: sum of 3 quarters · filed 2020-02-27 | $22.60B derived: sum of 4 quarters · filed 2020-02-27 | ||||
| 2018-04-01 | $3.57B 10-Q · filed 2019-05-09 | $15.86B derived: sum of 2 quarters · filed 2020-02-27 | $18.72B derived: sum of 3 quarters · filed 2020-02-27 | $21.80B derived: sum of 4 quarters · filed 2020-02-27 | ||||
| 2017-12-31 | $12.29B derived: 10-K 12 month − 10-Q 9 month · filed 2020-02-27 | $15.15B derived: sum of 2 quarters · filed 2020-02-27 | $18.22B derived: sum of 3 quarters · filed 2020-02-27 | $21.35B 10-K · filed 2020-02-27 | ||||
| 2017-10-01 | $2.86B 10-Q · filed 2018-11-08 | $5.93B derived: sum of 2 quarters · filed 2018-11-08 | $9.06B 10-Q · filed 2018-11-08 | $9.83B derived: sum of 4 quarters · filed 2019-02-28 | ||||
| 2017-07-02 | $3.08B 10-Q · filed 2018-08-09 | $6.21B 10-Q · filed 2018-08-09 | $6.97B derived: sum of 3 quarters · filed 2019-02-28 | $8.33B derived: sum of 4 quarters · filed 2019-02-28 | ||||
| 2017-04-02 | $3.13B 10-Q · filed 2018-05-10 | $3.89B derived: sum of 2 quarters · filed 2019-02-28 | $5.25B derived: sum of 3 quarters · filed 2019-02-28 | $7.31B derived: sum of 4 quarters · filed 2019-02-28 | ||||
| 2016-12-31 | $764.00M derived: 10-K 12 month − 10-Q 9 month · filed 2019-02-28 | $2.12B derived: sum of 2 quarters · filed 2019-02-28 | $4.18B derived: sum of 3 quarters · filed 2019-02-28 | $7.23B 10-K · filed 2019-02-28 | ||||
| 2016-10-02 | $1.35B 10-Q · filed 2017-11-09 | $1.32B 10-Q · filed 2016-11-10 | $3.42B derived: sum of 2 quarters · filed 2017-11-09 | $6.46B 10-Q · filed 2017-11-09 | $6.38B 10-Q · filed 2016-11-10 | $6.30B derived: sum of 4 quarters · filed 2018-02-22 | ||
| 2016-07-03 | $2.06B 10-Q · filed 2017-08-10 | $2.04B 10-Q · filed 2016-08-11 | $5.11B 10-Q · filed 2017-08-10 | $5.06B 10-Q · filed 2016-08-11 | $4.94B derived: sum of 3 quarters · filed 2018-02-22 | $7.07B derived: sum of 4 quarters · filed 2018-02-22 | ||
| 2016-04-03 | $3.05B 10-Q · filed 2017-05-11 | $3.03B 10-Q · filed 2016-05-12 | $2.88B derived: sum of 2 quarters · filed 2018-02-22 | $5.01B derived: sum of 3 quarters · filed 2018-02-22 | $7.65B derived: sum of 4 quarters · filed 2018-02-22 | |||
| 2015-12-31 | -$166.00M derived: 10-K 12 month − 10-Q 9 month · filed 2018-02-22 | $1.96B derived: sum of 2 quarters · filed 2018-02-22 | $4.60B derived: sum of 3 quarters · filed 2018-02-22 | $6.97B 10-K · filed 2018-02-22 | ||||
| 2015-09-27 | $2.13B 10-Q · filed 2016-11-10 | $4.76B derived: sum of 2 quarters · filed 2016-11-10 | $7.14B 10-Q · filed 2016-11-10 | $8.40B derived: sum of 4 quarters · filed 2017-02-23 | ||||
| 2015-06-28 | $2.63B 10-Q · filed 2016-08-11 | $5.01B 10-Q · filed 2016-08-11 | $6.27B derived: sum of 3 quarters · filed 2017-02-23 | $8.94B derived: sum of 4 quarters · filed 2017-02-23 | ||||
| 2015-03-29 | $2.38B 10-Q · filed 2016-05-12 | $3.63B derived: sum of 2 quarters · filed 2017-02-23 | $6.31B derived: sum of 3 quarters · filed 2017-02-23 | $9.23B derived: sum of 4 quarters · filed 2017-02-23 | ||||
| 2014-12-31 | $1.26B derived: 10-K 12 month − 10-Q 9 month · filed 2017-02-23 | $3.93B derived: sum of 2 quarters · filed 2017-02-23 | $6.85B derived: sum of 3 quarters · filed 2017-02-23 | $9.12B 10-K · filed 2017-02-23 | ||||
| 2014-09-28 | $2.68B 10-Q · filed 2015-11-05 | $5.60B derived: sum of 2 quarters · filed 2015-11-05 | $7.86B 10-Q · filed 2015-11-05 | $10.49B derived: sum of 4 quarters · filed 2016-02-29 | ||||
| 2014-06-29 | $2.92B 10-Q · filed 2015-08-06 | $5.19B 10-Q · filed 2015-08-06 | $7.82B derived: sum of 3 quarters · filed 2016-02-29 | $10.40B derived: sum of 4 quarters · filed 2016-02-29 | ||||
| 2014-03-30 | $2.27B 10-Q · filed 2015-05-07 | $4.90B derived: sum of 2 quarters · filed 2016-02-29 | $7.48B derived: sum of 3 quarters · filed 2016-02-29 | $11.06B derived: sum of 4 quarters · filed 2016-02-29 | ||||
| 2013-12-31 | $2.63B derived: 10-K 12 month − 10-Q 9 month · filed 2016-02-29 | $5.22B derived: sum of 2 quarters · filed 2016-02-29 | $8.79B derived: sum of 3 quarters · filed 2016-02-29 | $11.41B 10-K · filed 2016-02-29 | ||||
| 2013-09-29 | $2.59B 10-Q · filed 2014-11-06 | $6.16B derived: sum of 2 quarters · filed 2014-11-06 | $8.78B 10-Q · filed 2014-11-06 | $10.26B derived: sum of 4 quarters · filed 2015-02-27 | ||||
| 2013-06-30 | $3.58B 10-Q · filed 2014-08-07 | $6.19B 10-Q · filed 2014-08-07 | $7.67B derived: sum of 3 quarters · filed 2015-02-27 | $10.66B derived: sum of 4 quarters · filed 2015-02-27 | ||||
| 2013-03-31 | $2.62B 10-Q · filed 2014-05-08 | $2.76B 10-Q · filed 2013-05-10 | $4.09B derived: sum of 2 quarters · filed 2015-02-27 | $7.08B derived: sum of 3 quarters · filed 2015-02-27 | $10.08B derived: sum of 4 quarters · filed 2015-02-27 | |||
| 2012-12-31 | $1.48B derived: 10-K 12 month − 10-Q 9 month · filed 2015-02-27 | $4.47B derived: sum of 2 quarters · filed 2015-02-27 | $7.47B derived: sum of 3 quarters · filed 2015-02-27 | $9.02B 10-K · filed 2015-02-27 | $9.52B 10-K · filed 2013-02-28 | |||
| 2012-09-30 | $2.99B 10-Q · filed 2013-11-08 | $3.11B 10-Q · filed 2012-11-09 | $5.99B derived: sum of 2 quarters · filed 2013-11-08 | $7.54B 10-Q · filed 2013-11-08 | $8.03B 10-Q · filed 2012-11-09 | $8.59B derived: sum of 4 quarters · filed 2014-02-28 | ||
| 2012-07-01 | $3.00B 10-Q · filed 2013-08-09 | $3.19B 10-Q · filed 2012-08-09 | $4.55B 10-Q · filed 2013-08-09 | $4.92B 10-Q · filed 2012-08-09 | $5.60B derived: sum of 3 quarters · filed 2014-02-28 | $7.93B derived: sum of 4 quarters · filed 2014-02-28 | ||
| 2012-04-01 | $1.72B 10-Q · filed 2013-05-10 | $1.80B 10-Q · filed 2012-05-10 | $2.60B derived: sum of 2 quarters · filed 2014-02-28 | $4.93B derived: sum of 3 quarters · filed 2014-02-28 | $7.45B derived: sum of 4 quarters · filed 2014-02-28 | |||
| 2011-12-31 | $878.00M derived: 10-K 12 month − 10-Q 9 month · filed 2014-02-28 | $3.20B derived: sum of 2 quarters · filed 2014-02-28 | $5.72B derived: sum of 3 quarters · filed 2014-02-28 | $7.86B 10-K · filed 2014-02-28 | $8.74B 10-K · filed 2012-02-28 | |||
| 2011-10-02 | $2.33B 10-Q · filed 2012-11-09 | $2.43B 10-Q · filed 2011-11-10 | $4.85B derived: sum of 2 quarters · filed 2012-11-09 | $6.98B 10-Q · filed 2012-11-09 | $7.25B 10-Q · filed 2011-11-10 | $9.99B derived: sum of 4 quarters · filed 2013-02-28 | ||
| 2011-07-03 | $2.59B 10-Q · filed 2011-08-11 | $4.66B 10-Q · filed 2012-08-09 | $4.81B 10-Q · filed 2011-08-11 | $7.67B derived: sum of 3 quarters · filed 2013-02-28 | $8.52B derived: sum of 4 quarters · filed 2013-02-28 | |||
| 2011-04-03 | $2.22B 10-Q · filed 2012-05-10 | $5.15B derived: sum of 2 quarters · filed 2013-02-28 | $6.00B derived: sum of 3 quarters · filed 2013-02-28 | $8.46B derived: sum of 4 quarters · filed 2013-02-28 | ||||
| 2010-12-31 | $2.92B derived: 10-K 12 month − 10-Q 9 month · filed 2013-02-28 | $3.78B derived: sum of 2 quarters · filed 2013-02-28 | $6.23B derived: sum of 3 quarters · filed 2013-02-28 | $8.32B 10-K · filed 2013-02-28 | $8.30B 10-K · filed 2011-02-28 | |||
| 2010-10-03 | $856.00M 10-Q · filed 2011-11-10 | $876.00M 10-Q · filed 2010-11-12 | $3.31B derived: sum of 2 quarters · filed 2011-11-10 | $5.32B 10-Q · filed 2011-11-10 | $5.98B derived: sum of 4 quarters · filed 2012-02-28 | |||
| 2010-07-04 | $2.45B 10-Q · filed 2011-08-11 | $2.49B 10-Q · filed 2010-08-12 | $4.47B 10-Q · filed 2011-08-11 | $5.13B derived: sum of 3 quarters · filed 2012-02-28 | $8.01B derived: sum of 4 quarters · filed 2012-02-28 | |||
| 2010-04-04 | $2.01B 10-Q · filed 2011-05-12 | $2.03B 10-Q · filed 2010-05-13 | $2.67B derived: sum of 2 quarters · filed 2012-02-28 | $5.55B derived: sum of 3 quarters · filed 2012-02-28 | $7.81B derived: sum of 4 quarters · filed 2012-02-28 | |||
| 2009-12-31 | $658.00M derived: 10-K 12 month − 10-Q 9 month · filed 2012-02-28 | $3.54B derived: sum of 2 quarters · filed 2012-02-28 | $5.80B derived: sum of 3 quarters · filed 2012-02-28 | $8.53B 10-K · filed 2012-02-28 | $8.63B 10-K · filed 2010-02-26 | |||
| 2009-09-27 | $2.88B 10-Q · filed 2010-11-12 | $5.14B derived: sum of 2 quarters · filed 2010-11-12 | $7.87B 10-Q · filed 2010-11-12 | $8.10B derived: sum of 4 quarters · filed 2011-02-28 | ||||
| 2009-06-28 | $2.26B 10-Q · filed 2010-08-12 | $4.99B 10-Q · filed 2010-08-12 | $5.22B derived: sum of 3 quarters · filed 2011-02-28 | $7.48B derived: sum of 4 quarters · filed 2011-02-28 | ||||
| 2009-03-29 | $2.73B 10-Q · filed 2010-05-13 | $2.96B derived: sum of 2 quarters · filed 2011-02-28 | $5.22B derived: sum of 3 quarters · filed 2011-02-28 | $7.98B derived: sum of 4 quarters · filed 2011-02-28 | ||||
| 2008-12-31 | $231.00M derived: 10-K 12 month − 10-Q 9 month · filed 2011-02-28 | $2.49B derived: sum of 2 quarters · filed 2011-02-28 | $5.25B derived: sum of 3 quarters · filed 2011-02-28 | $8.05B 10-K · filed 2011-02-28 | ||||
| 2008-09-28 | $2.26B 10-Q · filed 2009-11-05 | $5.02B derived: sum of 2 quarters · filed 2009-11-05 | $7.82B 10-Q · filed 2009-11-05 | |||||
| 2008-06-29 | $2.77B 10-Q · filed 2009-08-06 | $5.56B 10-Q · filed 2009-08-06 | ||||||
| 2007-12-31 | $8.26B 10-K · filed 2010-02-26 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| ABBOTT LABORATORIES (ABT) | United States | $176.045B | 28.47 |
| VERTEX PHARMACEUTICALS INC / MA (VRTX) | United States | $132.481B | 28.56 |
| BRISTOL MYERS SQUIBB CO (BMY) | United States | $125.637B | 12.67 |
| REGENERON PHARMACEUTICALS, INC. (REGN) | United States | $74.751B | 21.53 |
| ALNYLAM PHARMACEUTICALS, INC. (ALNY) | United States | $33.420B | 54.94 |
| Zoetis Inc. (ZTS) | United States | $29.045B | 11.38 |
| INSMED Inc (INSM) | United States | $26.566B | -26.60 |
| Roivant Sciences Ltd. (ROIV) | $26.105B | -96.08 | |
| Royalty Pharma plc (RPRX) | United States | $22.628B | |
| UNITED THERAPEUTICS Corp (UTHR) | United States | $20.249B | 17.64 |